Novonesis Balance Sheet Health
Financial Health criteria checks 5/6
Novonesis has a total shareholder equity of €11.0B and total debt of €2.0B, which brings its debt-to-equity ratio to 18.1%. Its total assets and total liabilities are €15.3B and €4.2B respectively. Novonesis's EBIT is €525.0M making its interest coverage ratio 15.7. It has cash and short-term investments of €260.8M.
Key information
18.1%
Debt to equity ratio
€1.99b
Debt
Interest coverage ratio | 15.7x |
Cash | €260.80m |
Equity | €11.01b |
Total liabilities | €4.25b |
Total assets | €15.25b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NZM's short term assets (€1.8B) exceed its short term liabilities (€1.6B).
Long Term Liabilities: NZM's short term assets (€1.8B) do not cover its long term liabilities (€2.6B).
Debt to Equity History and Analysis
Debt Level: NZM's net debt to equity ratio (15.7%) is considered satisfactory.
Reducing Debt: NZM's debt to equity ratio has reduced from 36.2% to 18.1% over the past 5 years.
Debt Coverage: NZM's debt is well covered by operating cash flow (44.8%).
Interest Coverage: NZM's interest payments on its debt are well covered by EBIT (15.7x coverage).